Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Exploring the development of dual-payload anti-GPC3 antibody-drug conjugates for hepatocellular carcinoma treatment - a breakthrough in targeted cancer therapy